Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs [Yahoo! Finance]
Phibro Animal Health Corporation - Class A (PAHC)
Last phibro animal health corporation - class a earnings: 2/3 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pahc.com/investor-relations
Company Research
Source: Yahoo! Finance
and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals. This agreement grants Phibro exclusive rights to develop, manufacture, and commercialize Lighthouse Pharma's proprietary compound for canine periodontal care. The compound represents a promising advancement in veterinary dental health, addressing a widespread and often under-treated condition in dogs. "We are excited to partner with Lighthouse Pharma to help develop and commercialize a new solution for periodontal disease, which affects the majority of adult dogs and can have serious systemic consequences," said Daniel Bendheim, Executive Vice President, Corporate Strategy at Phibro. "This licensing agreement reflects our commitment to expanding our companion animal portfolio with innovative, science-driven products that improve animal well-being and strengthen the bond between pets and their
Show less
Read more
Impact Snapshot
Event Time:
PAHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAHC alerts
High impacting Phibro Animal Health Corporation - Class A news events
Weekly update
A roundup of the hottest topics
PAHC
News
- Phibro Animal Health (PAHC): Revisiting Valuation After a Near 100% Year-to-Date Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Zacks.com featured highlights include Phibro Animal Health, Argan and Ubiquiti [Yahoo! Finance]Yahoo! Finance
- Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Phibro Animal Health (NASDAQ:PAHC) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Phibro Animal Health (NASDAQ:PAHC) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
PAHC
Earnings
- 11/5/25 - Beat
PAHC
Analyst Actions
- 11/7/25 - JP Morgan
PAHC
Sec Filings
- 12/4/25 - Form 4
- 12/4/25 - Form 144
- 12/2/25 - Form 4
- PAHC's page on the SEC website